论文部分内容阅读
拉米夫定是乙型肝炎病毒 (ＨＢＶ)复制的有效抑制剂 ,在治疗慢性乙型肝炎方面已经显示出引人注目的效果。不过 ,该药对于慢性ＨＢＶ感染发生自发性严重性急性转剧 (ＳＡＥ)病人的效果尚不清楚。本研究旨在验证这一问题。方法 1 997年 9月～ 1 999年 6月Ｔｏｒａ ｎｏｍｏｎ医
Lamivudine is a potent inhibitor of hepatitis B virus (HBV) replication and has shown compelling results in the treatment of chronic hepatitis B. However, the effect of this drug on patients with spontaneous serious acute exacerbation (SAE) of chronic HBV infection remains unclear. This study aims to validate this issue. Method 1 Tora nomon from September 1997 to June 1999